257 related articles for article (PubMed ID: 33762121)
21. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
22. Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.
Schiapparelli P; Enguita-Germán M; Balbuena J; Rey JA; Lázcoz P; Castresana JS
Oncol Rep; 2010 Nov; 24(5):1355-62. PubMed ID: 20878131
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum.
Persson CU; von Stedingk K; Bexell D; Merselius M; Braekeveldt N; Gisselsson D; Arsenian-Henriksson M; Påhlman S; Wigerup C
Sci Rep; 2017 Aug; 7(1):10274. PubMed ID: 28860499
[TBL] [Abstract][Full Text] [Related]
24. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
[TBL] [Abstract][Full Text] [Related]
25. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
26. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
[TBL] [Abstract][Full Text] [Related]
28. O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
Cheng JY; Hung JT; Lin J; Lo FY; Huang JR; Chiou SP; Wang YH; Lin RJ; Wu JC; Yu J; Yu AL
Front Immunol; 2021; 12():791551. PubMed ID: 35046949
[TBL] [Abstract][Full Text] [Related]
29. Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics.
Zheng X; Naiditch J; Czurylo M; Jie C; Lautz T; Clark S; Jafari N; Qiu Y; Chu F; Madonna MB
Cell Death Dis; 2013 Jul; 4(7):e740. PubMed ID: 23887631
[TBL] [Abstract][Full Text] [Related]
30. Patient-derived xenografts as preclinical neuroblastoma models.
Braekeveldt N; Bexell D
Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
[TBL] [Abstract][Full Text] [Related]
31. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
32. CD133
Liu K; Hao M; Ouyang Y; Zheng J; Chen D
Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
[TBL] [Abstract][Full Text] [Related]
33. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
34. Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.
Villasante A; Sakaguchi K; Kim J; Cheung NK; Nakayama M; Parsa H; Okano T; Shimizu T; Vunjak-Novakovic G
Theranostics; 2017; 7(17):4099-4117. PubMed ID: 29158813
[TBL] [Abstract][Full Text] [Related]
35. Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells.
Ferrari-Toninelli G; Bonini SA; Uberti D; Buizza L; Bettinsoli P; Poliani PL; Facchetti F; Memo M
Neuro Oncol; 2010 Dec; 12(12):1231-43. PubMed ID: 20716592
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.
Nishimura N; Hartomo TB; Pham TV; Lee MJ; Yamamoto T; Morikawa S; Hasegawa D; Takeda H; Kawasaki K; Kosaka Y; Yamamoto N; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Iijima K; Matsuo M; Nishio H
Environ Health Prev Med; 2012 May; 17(3):246-51. PubMed ID: 21909813
[TBL] [Abstract][Full Text] [Related]
37. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin.
Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B
Gene; 2022 May; 821():146333. PubMed ID: 35182674
[TBL] [Abstract][Full Text] [Related]
38. [The Effect of Morusin on Stemness Phenotype of Laryngeal Cancer Stem Cell].
Chen C; Xu ZH; Wang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):650-657. PubMed ID: 32975079
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer stem cell-derived exosomal long intergenic noncoding RNA 01315 (LINC01315) promotes proliferation, migration, and stemness of colorectal cancer cells.
Li Y; Wu M; Xu S; Huang H; Yan L; Gu Y
Bioengineered; 2022 Apr; 13(4):10827-10842. PubMed ID: 35470736
[TBL] [Abstract][Full Text] [Related]
40. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
